Higher levels of miR‐9 were also detected in the serum of SMA mice, and were reduced by morpholino treatment that up‐regulated SMN; these miRNA level changes occurred much earlier than the changes in level in the spinal cord and skeletal muscle. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.